Saturday - October 3, 2026
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer
October 01, 2026
BUFFALO, New York, Oct. 1 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:

* * *

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer

*

BUFFALO, N.Y. and SOMERVILLE, Mass. -Roswell Park Comprehensive Cancer Center ("Roswell Park") and Generate Biomedicines, Inc. ("Generate") today announced that th . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products